FDA Approvals

Date Posted
Article Title
6/20/2011
Abuse-Resistant Oxycodone Approved

Oxecta ingredient discourages extra doses

6/16/2011
Nulojix Approved to Help Thwart Kidney Rejection

For adults who have had kidney transplant

6/14/2011
First Ceramic-on-Metal Hip Replacement Approved

For people with osteoarthritis

6/14/2011
6/13/2011
Potiga Approved for Adult Epileptic Seizures

But drug may cause 'neuro-psychiatric' side effects, FDA says

6/10/2011
5/31/2011
Solesta Gel Approved for Fecal Incontinence

A condition affecting 5.5 million Americans

5/31/2011
Dificid Approved to Treat C. diff Diarrhea

Bacterial infection commonly acquired in hospitals

5/23/2011
Incivek Approved for Hepatitis C

Among people who haven't received or responded to standard interferon

5/23/2011
Sutent Approved for Rare Pancreatic Cancer

For inoperable or spreading tumors

5/20/2011
5/20/2011
Edurant Approved To Treat AIDS Virus

In combination with other antiretroviral drugs

5/19/2011
New Test Detects Recent Infection With Toxoplasmosis

Parasite dangerous to pregnant women

5/16/2011
Victrelis Approved for Chronic Hepatitis C

In combination with two other drugs

5/6/2011
FDA OK's Test to Spot Drug-Resistant Staph

Just-approved diagnostic identifies MRSA infections

5/6/2011
FDA Sanctions Wider Use of Carotid Stent

For people with clogged neck artery

5/6/2011
Afinitor Approved for Rare Pancreatic Cancer

Extended survival in clinical studies

5/2/2011
Tradjenta Approved for Type 2 Diabetes

The disease's most common form

4/29/2011
Zytiga Approved for Advanced Prostate Cancer

FDA: Improved patient survival shown in clinical testing

4/25/2011